COSMED announces U.S. FDA 510(K) clearance of Q-NRG+ and Q-NRG Indirect Calorimetry device.
The FDA has granted marketing approval for the device in the US market where we expect to launch the product during the next ASPEN 2020 Nutrition conference taking place in Tampa, FL on March 28-31.
Q-NRG is a result of COSMED’s collaboration with world-class institutes in the field of nutrition support in intensive care units. Product concept and specifications have been designed together with the ICALIC Clinical Trial study group; this collaboration made possible the development of an accurate metabolic system simple to use and, at the same time, able to solve all typical pitfalls of Indirect Calorimetry technology with clear advantages compared to Predictive Equations.
Get in touch
COSMED strives to provide the best service possible with every contact!
Fill the online forms to get the info you're looking for right now!